AlzChem Group
ACT.DE
#6300
Rank
A$0.97 B
Marketcap
$94.95
Share price
5.43%
Change (1 day)
151.92%
Change (1 year)

P/E ratio for AlzChem Group (ACT.DE)

P/E ratio as of November 2024 (TTM): 16.1

According to AlzChem Group's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 16.0572. At the end of 2023 the company had a P/E ratio of 7.65.

P/E ratio history for AlzChem Group from 2018 to 2024

PE ratio at the end of each year

Year P/E ratio Change
20237.6533.94%
20225.71-33.63%
20218.60-22.01%
202011.0-8.76%
201912.1363.47%
20182.61-13.04%
20173.00-106.44%
2016-46.67.82%
2015-43.2-74.19%
2014-167-0%
2013-167-21.92%
2012-214-25.88%
2011-289183.21%
2010-102-69.78%
2009-338-60.59%
2008-858

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.